Anti-MAP2K2 Polyclonal Antibody (CABT-L2275) Knockout Validated

Rabbit Anti-Human MAP2K2 (Val86~Pro331) Polyclonal Antibody for WB

Specifications


Host Species
Rabbit
Antibody Isotype
IgG
Species Reactivity
Human
Immunogen
Recombinant fragment corresponding to human MAP2K2 (Val86~Pro331)
Conjugate
Unconjugated

Applications


Application Notes
Recommended dilution: WB: 1-5 ug/ml
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.

Data Examples


Knockout Varification: Lane 1: Wild-type Hela cell lysate. Lane 2: MAP2K2 knockout Hela cell lysate. Predicted MW: 44kd, Observed MW: 44kd
Figure. Western Blot. Sample. Lane1: Human Jurkat cells; Lane2: Human Hela cels.

Target


Alternative Names
MAPKK2; MEK2; MKK2; PRKMK2; ERK activator kinase 2; Dual specificity mitogen-activated protein kinase kinase 2
Entrez Gene ID
UniProt ID

Product Background


Pathway
ARMS-mediated activation; Activated TLR4 signalling; Acute myeloid leukemia; Amyotrophic lateral sclerosis (ALS); Axon guidance; B Cell Receptor Signaling Pathway; B cell receptor signaling pathway; BDNF signaling pathway;

Citations


Have you cited CABT-L2275 in a publication? Let us know and earn a reward for your research.

Custom Antibody Labeling


We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More

Customer Reviews


Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket

References


Leich, E; Weissbach, S; et al. Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules. BLOOD CANCER JOURNAL 3:-(2013).
MacDonald, TJ; Brown, KM; et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. NATURE GENETICS 29:143-152(2001).

Online Inquiry

Name:
Phone: *
E-mail Address: *
Service & Products Interested: *
Project Description:
Verification Code: * Please input "diagnostics" as verification code.

Online Inquiry

  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket